日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft

三阴性乳腺癌患者异种移植中卡铂耐药性获得过程中 3D 基因组的重新连接

Mikhail G Dozmorov #, Maggie A Marshall #, Narmeen S Rashid, Jacqueline M Grible, Aaron Valentine, Amy L Olex, Kavita Murthy, Abhijit Chakraborty, Joaquin Reyna, Daniela Salgado Figueroa, Laura Hinojosa-Gonzalez, Erika Da-Inn Lee, Brittany A Baur, Sushmita Roy, Ferhat Ay, J Chuck Harrell

Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies

DR5 激动剂抗体在 TNBC、卵巢癌和其他实体瘤中表现出意想不到的 PD-L1 免疫逃避机制

Tanmoy Mondal, Gururaj N Shivange, Rachisan Gt Tihagam, Evan Lyerly, Michael Battista, Divpriya Talwar, Roxanna Mosavian, Karol Urbanek, Narmeen S Rashid, J Chuck Harrell, Paula D Bos, Edward B Stelow, M Sharon Stack, Sanchita Bhatnagar, Jogender Tushir-Singh

Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies

DR5激动剂抗体在三阴性乳腺癌、卵巢癌和其他实体瘤中揭示出意想不到的PD-L1免疫逃逸机制

Tanmoy Mondal,Gururaj N Shivange,Rachisan Gt Tihagam,Evan Lyerly ,Michael Battista ,Divpriya Talwar ,Roxanna Mosavian ,Karol Urbanek,Narmeen S Rashid,J Chuck Harrell,Paula D Bos,Edward B Stelow,M Sharon Stack,Sanchita Bhatnagar,Jogender Tushir-Singh

Identification of nuclear export inhibitor-based combination therapies in preclinical models of triple-negative breast cancer

在三阴性乳腺癌临床前模型中鉴定基于核输出抑制剂的联合疗法

Narmeen S Rashid, Nicole S Hairr, Graeme Murray, Amy L Olex, Tess J Leftwich, Jacqueline M Grible, Jason Reed, Mikhail G Dozmorov, J Chuck Harrell